Answers are grounded in this paper and cite their sources.
Background: Despite the general safety of liposuction and fat grafting procedures, surgical-site infections (SSIs) remain a significant concern. These infections, ranging from minor to severe, can arise from various sources and pose a substantial burden. The overuse of antibiotics has led to increased antimicrobial resistance, highlighting the need for alternative infection prevention strategies like stabilized hypochlorous acid (s-HOCl). Objectives: The aim of the authors of this study is to evaluate the efficacy and safety of s-HOCl in preventing SSIs following liposculpture and other body contouring procedures. Methods: A prospective cohort study and matched control cohort were conducted at a single plastic surgery center in Bogota, Colombia (Dhara Clinic). Adult patients scheduled for liposculpture and fat grafting from January 2020 to December 2023 formed the intervention group, receiving s-HOCl as a washing solution for adipose grafts. A matched control cohort was drawn from patients who underwent similar procedures from January 2017 to December 2019 without s-HOCl. Data on demographics, surgical characteristics, and SSI outcomes were collected and analyzed. Results: A total of 1008 patients were included, with 502 in the s-HOCl group and 506 in the control group. The infection rate in the s-HOCl group was 0.2 per 100 grafted muscles, compared with 0.54 in the control group. Relative risk of SSIs in the s-HOCl group was 0.4, indicating a reduction in infection rates. The small absolute risk reduction of 0.59% underscores the clinical importance, considering SSIs, although rare, are severe and life-threatening events, with significant impact on outcomes and healthcare costs. A reduction in the severity of infection and the level of required treatment was also observed. Conclusions: s-HOCl demonstrated potential to reduce SSI risk following liposuction and fat grafting. This intervention offers a valuable alternative to antibiotics, effectively reducing infection rates and contributing to improved patient outcomes and public health in postantibiotic era.
No takes yet. Share an insight, caveat, or question.
Hoyos et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: